Abstract：
The Swedish national guidelines for epilepsy stipulate regular health care contacts in the years following diagnosis, referral for epilepsy surgery in cases of pharmacoresistant epilepsy, multidisciplinary teams, and adequate patient information particularly for women of childbearing age. The last years have seen advances in many research areas of relevance for the basic epilepsy care, and Sweden has contributed regarding pharmacotherapy, seizure-related risks, sudden unexpected death in epilepsy (SUDEP), and digital tools. An increasing prevalence of epilepsy and stagnating or decreasing health care resources makes nationwide implementation of this knowledge challenging and increases the risk of unequal access to care. Innovation and focus on prioritized groups, such as newly diagnosed and persons with pharmacoresistant epilepsy or comorbidities, will be needed.
摘要：
瑞典国家癫痫指南规定，在诊断后的几年内定期进行医疗保健接触。药物耐药性癫痫患者的癫痫手术转诊，多学科团队，以及充分的患者信息，特别是对于育龄妇女。在过去的几年中，许多与基本癫痫护理相关的研究领域取得了进展，瑞典在药物治疗方面做出了贡献，与癫痫发作相关的风险，癫痫猝死（SUDEP），数字工具。癫痫患病率的增加以及医疗保健资源的停滞或减少，使得在全国范围内实施这种知识具有挑战性，并增加了获得护理机会不平等的风险。创新和关注优先群体，如新诊断和患有药物抗性癫痫或合并症的人，将需要。
